Predictive value of phosphorylated mammalian target of rapamycin for disease-free survival in breast cancer patients receiving neoadjuvant chemotherapy.

Wang, Shuo; Sun, Yiqun; He, Anning; Zheng, Caiwei; Zheng, Xinyu

Wang, Shuo; Sun, Yiqun; He, Anning; Zheng, Caiwei; Zheng, Xinyu.

Afiliación

Wang S; Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China.
Sun Y; Department of Burns, General Hospital of Benxi Iron and Steel Company, Benxi, Liaoning 117000, P.R. China.
He A; Lab 1, Cancer Institute, China Medical University, Shenyang, Liaoning 110001, P.R. China.
Zheng C; Department of Biology, Brandeis University, Waltham, MA 02453, USA.
Zheng X; Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China ; Lab 1, Cancer Institute, China Medical University, Shenyang, Liaoning 110001, P.R. China.

Oncol Lett ; 8(6): 2642-2648, 2014 Dec.

Article en En | MEDLINE | ID: mdl-25364442

Palabras clave

neoadjuvant chemotherapy; phosphorylated-eukaryotic translation initiation factor 4E-binding protein; phosphorylated-mammalian target of rapamycin; predictive value

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Oncol Lett Año: 2014 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google